Status:
COMPLETED
Re-Aiming at Hydroxyurea Adherence for Sickle Cell With mHealth
Lead Sponsor:
St. Jude Children's Research Hospital
Collaborating Sponsors:
University of Memphis
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Sickle Cell Disease
Eligibility:
All Genders
15-44 years
Brief Summary
National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) guidelines recommend that hydroxyurea be offered to symptomatic adults and all children with sickle cell disease (...
Detailed Description
Data for the needs assessment and pilot trial will be collected from the patients via validated surveys, qualitative methods (e.g., interviews and focus groups), and medical record abstraction. The s...
Eligibility Criteria
Inclusion
- Diagnosis of sickle cell disease (any genotype)
- Between the ages of 15 and 44.9 years
- English-speaking
Exclusion
- Inability or unwillingness of research participant or legal guardian/representative to give written informed consent
Key Trial Info
Start Date :
December 5 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 28 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03344900
Start Date
December 5 2017
End Date
June 28 2018
Last Update
December 11 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Jude Children's Research Hospital
Memphis, Tennessee, United States, 38105
2
Baptist Memorial Hospital, Baptist Clinical Research Institute
Memphis, Tennessee, United States, 38120